A genetic marker for elevated levels of haemoglobin F in homozygous sickle cell disease?

Br J Haematol. 1985 Jun;60(2):261-8. doi: 10.1111/j.1365-2141.1985.tb07412.x.

Abstract

Ten patients with sickle cell (SS) disease from a Jamaican family were found to have unusually high levels of haemoglobin F for this population. Each of them has inherited one sickle cell gene on a chromosome characterized by an arrangement of restriction fragment length polymorphisms (haplotype) which is very rare in the Jamaican population. Genetic analysis of the family suggests that there is a determinant linked to the beta-globin gene cluster, characterized by this haplotype, which is responsible for increased haemoglobin F production in response to anaemia. Interestingly this particular haplotype appears to be common in patients with SS disease in eastern Saudi Arabia in whom a high level of haemoglobin F is the rule rather than the exception. Hence it is possible that this haplotype (++-++) acts as a genetic marker for elevated levels of haemoglobin F in sickle cell disease.

MeSH terms

  • Anemia, Sickle Cell / genetics*
  • Female
  • Fetal Hemoglobin / genetics*
  • Genetic Markers*
  • Haploidy
  • Humans
  • Jamaica
  • Male
  • Pedigree
  • Saudi Arabia
  • Sickle Cell Trait / genetics*

Substances

  • Genetic Markers
  • Fetal Hemoglobin